Lunit (KRX:328130), a South Korea-based company that provides AI-powered solutions for cancer diagnostics and therapeutics, announced on Wednesday that it has partnered with Salud Digna, a Mexican medical network.

Under the agreement Lunit will deliver its AI-powered medical imaging solutions to Salud Digna's network of more than 230 clinics across Mexico and Central America. Lunit will also gain access to Salud Digna's database of millions of deidentified 2D mammography and chest X-ray images. This high-quality data is intended to help Lunit to refine its AI algorithms, particularly for the Latin American market.

The deal centres on two of Lunit's flagship products: Lunit INSIGHT CXR, an AI-powered chest X-ray analysis solution, and Lunit INSIGHT MMG, an AI software for mammography analysis.

Salud Digna's CEO, Juan Carlos Ordonez, said: "By integrating Lunit's advanced AI into our healthcare network, we aim to improve the accuracy and efficiency of our imaging services. Together, we are committed to leveraging our extensive data resources to drive innovation in medical imaging and ultimately improve patient care across the region."